Phase one of a hybrid effectiveness-implementation study to assess the feasibility, acceptability and effectiveness of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique.

Saved in:
Bibliographic Details
Title: Phase one of a hybrid effectiveness-implementation study to assess the feasibility, acceptability and effectiveness of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique.
Authors: Baker K; Malaria Consortium, London, UK. kevin.baker@ki.se.; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden. kevin.baker@ki.se., Pulido Tarquino IA; Malaria Consortium, Maputo, Mozambique., Aide P; National Institute of Health (Instituto Nacional de Saúde), Maputo, Mozambique.; Centro de Investigação em Saúde de Manhiça, Manhiça, Mozambique., Bonnington C; Malaria Consortium, London, UK., Rassi C; Malaria Consortium, London, UK., Richardson S; Malaria Consortium, London, UK.; Vanke School of Public Health, Tsinghua University, Beijing, China., Nnaji C; Malaria Consortium, London, UK., Roca-Feltrer A; PATH, Maputo, Mozambique., Rodrigues M; Malaria Consortium, Maputo, Mozambique., Sitoe M; Malaria Consortium, Maputo, Mozambique., Enosse S; Malaria Consortium, Maputo, Mozambique., McGugan C; GiveWell, San Francisco, USA., Saute F; Centro de Investigação em Saúde de Manhiça, Manhiça, Mozambique., Matambisso G; Centro de Investigação em Saúde de Manhiça, Manhiça, Mozambique., Candrinho B; National Malaria Control Programme, Ministry of Health, Maputo, Mozambique.
Source: Malaria journal [Malar J] 2025 Feb 21; Vol. 24 (1), pp. 56. Date of Electronic Publication: 2025 Feb 21.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1475-2875
DOI:10.1186/s12936-024-05229-x